Last reviewed · How we verify
Probiotics
At a glance
| Generic name | Probiotics |
|---|---|
| Also known as | Lactobacillus, Bifidobacterium, Leveduras, Acetobacter, BLIS |
| Sponsor | Universidade Federal de Pernambuco |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study (PHASE2)
- Probiotic Intervention Study (NA)
- Nutritional Effects in Cardiovascular Surgery (NA)
- The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics (NA)
- Effect of L. Reuteri LM1063 on Sleep Health Improvement (NA)
- The Effects of a Probiotic Food Supplement in Hyperuricaemia (NA)
- The Gut - PRO Study (PHASE2)
- Precision Nutrition Recommendations Generated by Metataxonomic Microbiome Testing Improve Food Group Choices and Intestinal Health Indicators in an Obese Population in Colombia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Probiotics CI brief — competitive landscape report
- Probiotics updates RSS · CI watch RSS
- Universidade Federal de Pernambuco portfolio CI